title: [Cardiopulmonary effects of prostaglandin E1. Aspects of drug safety].
authors.affiliation: Franziskus-Krankenhaus, Berlin.
authors.forename: H
authors.initials: H
authors.lastname: Heidrich
authors.forename: H K
authors.initials: HK
authors.lastname: Breddin
authors.forename: G
authors.initials: G
authors.lastname: Rudofsky
authors.forename: P
authors.initials: P
authors.lastname: Scheffler
mesh_terms: D000527:Alprostadil / Q000009:adverse effects* / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D011654:Pulmonary Edema / Q000139:chemically induced*; D012307:Risk Factors
chemical_list: D000527:Alprostadil
vernacular_title: Kardiopulmonale Wirkungen von Prostaglandin E1. Aspekte zur Arzneimittelsicherheit.